Alaunos Therapeutics
TCRT
27 hedge funds and large institutions have $350K invested in Alaunos Therapeutics in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 5 closing their positions.
121% more capital invested
Capital invested by funds: $158K → $350K (+$192K)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
4% more funds holding
Funds holding: 26 → 27 (+1)
1.71% more ownership
Funds ownership: 2.97% → 4.68% (+1.7%)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$60.1K |
| 2 |
HF
HRT Financial
New York
|
+$40.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.8K |
| 5 |
Citigroup
New York
|
+$288 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.78K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$724 |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$288 |
| 4 |
Barclays
London,
United Kingdom
|
-$121 |
| 5 |
Morgan Stanley
New York
|
-$120 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TAM
26
Tucker Asset Management
Littleton,
Colorado
| $3 | +$3 | +1 | New |
|
|
27
Barclays
London,
United Kingdom
| – | -$121 | -50 | Closed |
|
|
ADL
28
Asset Dedication LLC
San Francisco,
California
| – | -$111 | -46 | Closed |
|
|
TC
29
Truvestments Capital
Sarasota,
Florida
| – | -$2 | -1 | Closed |
|
|
WANY
30
Wealthspire Advisors (New York)
New York
| – | -$3 | -1 | Closed |
|
TCRT Hedge Fund Activity: Q4 2025 in Review
27 of the 8,229 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q4 2025, worth a combined $350K — up 121% from $158K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new TCRT positions and 5 closed out — a net gain of 1 holder — while 2 added to existing stakes and 6 trimmed.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $60.1K. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.78K.
- 27 institutional investors held Alaunos Therapeutics (TCRT) as of Q4 2025, up from 26 in Q3 2025.
- Funds reported $350K of Alaunos Therapeutics stock for Q4 2025, up 121% quarter-over-quarter.
- 6 funds opened new Alaunos Therapeutics positions in Q4 2025 and 5 closed out, a net change of +1 holder.
- The largest Alaunos Therapeutics buyer in Q4 2025 was Two Sigma Investments, an estimated $60.1K added.
- The largest Alaunos Therapeutics seller in Q4 2025 was Tower Research Capital (TRC), an estimated $1.78K sold.
Based on aggregated 13F filings for Q4 2025.